FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061025008> ?p ?o ?g. }

• W2061025008 endingPage "161" @default.
• W2061025008 startingPage "154" @default.
• W2061025008 abstract "We used the Archimedes Model, a mathematical simulation model (Model) to estimate the clinical- and cost-effectiveness of using LDL particle concentration (LDL-P) as an adjunct or alternative to LDL cholesterol (LDL-C) to guide statin therapy. LDL-P by NMR has been shown to be a better measure of cardiovascular disease (CVD) risk than LDL-C, and may therefore be a better gauge of the need for and response to statin treatment. Using the Model, we conducted a virtual clinical trial comparing the use of LDL-C alone, LDL-P alone, and LDL-C and LDL-P together to guide treatment in the general adult population, and in high-risk, dyslipidemic subpopulations. In the general population, the 5-year major adverse cardiovascular event (MACE) relative risk reduction (RRR) of LDL-P alone compared to the control arm (LDL-C alone) was 5.0% (95% CI, 4.7-5.3; p < .0001); using both LDL-C and LDL-P (dual markers) led to 3.0% RRR compared to the control arm (95% CI, 2.8-3.3; p < .0001). For individuals with diabetes, the RRR was 7.3% (95% CI, 6.4-8.2; p < .0001) for LDL-P alone and 6.9% for dual markers (95% CI, 6.1-7.8; both, p < .0001). In the general population, the costs per quality-adjusted life year (QALY) associated with the use of LDL-P alone were $76,052 at 5 years and $8913 at 20 years and $142,825 at 5 years and $25,505 at 20 years with the use of both markers. In high-risk subpopulations, the use of LDL-P alone was cost-saving at 5 years; whereas the cost per QALY for the use of both markers was $14,250 at 5 years and $859 at 20 years for high-risk dyslipidemics, $19,192 at 5 years and $649 at 20 years for diabetics, and $9030 at 5 years and $7268 at 20 years for patients with prior CHD. In conclusion, the model estimates that using LDL-P to guide statin therapy may reduce the risk of CVD events to a greater extent than does the use of LDL-C alone and maybe cost-effective or cost-saving for high-risk patients." @default.
• W2061025008 created "2016-06-24" @default.
• W2061025008 creator A5025420200 @default.
• W2061025008 creator A5052211061 @default.
• W2061025008 creator A5062823386 @default.
• W2061025008 creator A5069833203 @default.
• W2061025008 creator A5079665496 @default.
• W2061025008 date "2014-09-01" @default.
• W2061025008 modified "2023-10-04" @default.
• W2061025008 title "Clinical- and cost-effectiveness of LDL particle-guided statin therapy: A simulation study" @default.
• W2061025008 cites W1807177598 @default.
• W2061025008 cites W1971574914 @default.
• W2061025008 cites W1971911987 @default.
• W2061025008 cites W1984875752 @default.
• W2061025008 cites W1990092121 @default.
• W2061025008 cites W1993707348 @default.
• W2061025008 cites W2009944328 @default.
• W2061025008 cites W2012344261 @default.
• W2061025008 cites W2022212051 @default.
• W2061025008 cites W2026002591 @default.
• W2061025008 cites W2033209427 @default.
• W2061025008 cites W2057924367 @default.
• W2061025008 cites W2062834072 @default.
• W2061025008 cites W2067684540 @default.
• W2061025008 cites W2070416921 @default.
• W2061025008 cites W2079979713 @default.
• W2061025008 cites W2092831846 @default.
• W2061025008 cites W2093213268 @default.
• W2061025008 cites W2107424758 @default.
• W2061025008 cites W2107443630 @default.
• W2061025008 cites W2108479359 @default.
• W2061025008 cites W2110171695 @default.
• W2061025008 cites W2127448855 @default.
• W2061025008 cites W2134306662 @default.
• W2061025008 cites W2148897749 @default.
• W2061025008 cites W2152354184 @default.
• W2061025008 cites W2156097706 @default.
• W2061025008 cites W2158057499 @default.
• W2061025008 cites W2162806971 @default.
• W2061025008 cites W2170376856 @default.
• W2061025008 cites W35016999 @default.
• W2061025008 cites W4236673002 @default.
• W2061025008 cites W4238251256 @default.
• W2061025008 doi "https://doi.org/10.1016/j.atherosclerosis.2014.06.027" @default.
• W2061025008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25050538" @default.
• W2061025008 hasPublicationYear "2014" @default.
• W2061025008 type Work @default.
• W2061025008 sameAs 2061025008 @default.
• W2061025008 citedByCount "16" @default.
• W2061025008 countsByYear W20610250082014 @default.
• W2061025008 countsByYear W20610250082016 @default.
• W2061025008 countsByYear W20610250082017 @default.
• W2061025008 countsByYear W20610250082018 @default.
• W2061025008 countsByYear W20610250082019 @default.
• W2061025008 countsByYear W20610250082020 @default.
• W2061025008 countsByYear W20610250082021 @default.
• W2061025008 countsByYear W20610250082022 @default.
• W2061025008 crossrefType "journal-article" @default.
• W2061025008 hasAuthorship W2061025008A5025420200 @default.
• W2061025008 hasAuthorship W2061025008A5052211061 @default.
• W2061025008 hasAuthorship W2061025008A5062823386 @default.
• W2061025008 hasAuthorship W2061025008A5069833203 @default.
• W2061025008 hasAuthorship W2061025008A5079665496 @default.
• W2061025008 hasBestOaLocation W20610250081 @default.
• W2061025008 hasConcept C126322002 @default.
• W2061025008 hasConcept C197934379 @default.
• W2061025008 hasConcept C2776839432 @default.
• W2061025008 hasConcept C2778096610 @default.
• W2061025008 hasConcept C2778163477 @default.
• W2061025008 hasConcept C2778657065 @default.
• W2061025008 hasConcept C2779134260 @default.
• W2061025008 hasConcept C2780400711 @default.
• W2061025008 hasConcept C2780739214 @default.
• W2061025008 hasConcept C2908647359 @default.
• W2061025008 hasConcept C3019550498 @default.
• W2061025008 hasConcept C500558357 @default.
• W2061025008 hasConcept C71924100 @default.
• W2061025008 hasConcept C90924648 @default.
• W2061025008 hasConcept C99454951 @default.
• W2061025008 hasConceptScore W2061025008C126322002 @default.
• W2061025008 hasConceptScore W2061025008C197934379 @default.
• W2061025008 hasConceptScore W2061025008C2776839432 @default.
• W2061025008 hasConceptScore W2061025008C2778096610 @default.
• W2061025008 hasConceptScore W2061025008C2778163477 @default.
• W2061025008 hasConceptScore W2061025008C2778657065 @default.
• W2061025008 hasConceptScore W2061025008C2779134260 @default.
• W2061025008 hasConceptScore W2061025008C2780400711 @default.
• W2061025008 hasConceptScore W2061025008C2780739214 @default.
• W2061025008 hasConceptScore W2061025008C2908647359 @default.
• W2061025008 hasConceptScore W2061025008C3019550498 @default.
• W2061025008 hasConceptScore W2061025008C500558357 @default.
• W2061025008 hasConceptScore W2061025008C71924100 @default.
• W2061025008 hasConceptScore W2061025008C90924648 @default.
• W2061025008 hasConceptScore W2061025008C99454951 @default.
• W2061025008 hasIssue "1" @default.
• W2061025008 hasLocation W20610250081 @default.
• W2061025008 hasLocation W20610250082 @default.
• W2061025008 hasLocation W20610250083 @default.

• next